| Primary |
| Hypotension |
32.3% |
| Drug Use For Unknown Indication |
29.0% |
| Vasopressive Therapy |
9.7% |
| Cardiac Disorder |
6.5% |
| Cerebral Disorder |
6.5% |
| Periarthritis |
6.5% |
| Restrictive Cardiomyopathy |
3.2% |
| Sedation |
3.2% |
| Septic Shock |
3.2% |
|
| Atrial Fibrillation |
5.0% |
| Confusional State |
5.0% |
| Coronary Artery Stenosis |
5.0% |
| Death |
5.0% |
| Device Occlusion |
5.0% |
| Hypotension |
5.0% |
| Hypothyroidism |
5.0% |
| Hypoxia |
5.0% |
| Injection Site Pallor |
5.0% |
| Intraventricular Haemorrhage Neonatal |
5.0% |
| Off Label Use |
5.0% |
| Peripheral Ischaemia |
5.0% |
| Pharmaceutical Product Complaint |
5.0% |
| Poor Weight Gain Neonatal |
5.0% |
| Post Viral Fatigue Syndrome |
5.0% |
| Product Quality Issue |
5.0% |
| Renal Failure Neonatal |
5.0% |
| Skin Discolouration |
5.0% |
| Tachyarrhythmia |
5.0% |
| Tachycardia |
5.0% |
|
| Secondary |
| Product Used For Unknown Indication |
12.9% |
| Drug Use For Unknown Indication |
10.7% |
| Anaesthesia |
7.5% |
| Cardiac Failure |
7.0% |
| Cardiac Disorder |
6.5% |
| Vasodilatation |
6.5% |
| Hypotension |
6.3% |
| Blood Pressure Management |
5.6% |
| Induction Of Anaesthesia |
4.9% |
| Sedation |
4.9% |
| Prophylaxis |
4.2% |
| Status Epilepticus |
3.7% |
| Pulmonary Hypertension |
3.0% |
| Maintenance Of Anaesthesia |
2.8% |
| Antibiotic Therapy |
2.6% |
| General Anaesthesia |
2.3% |
| Infection |
2.3% |
| Cardiac Failure Acute |
2.1% |
| Cardiac Failure Chronic |
2.1% |
| Analgesic Therapy |
1.9% |
|
| Hypotension |
12.3% |
| Ventricular Tachycardia |
8.8% |
| Cardiac Arrest |
7.0% |
| Wrong Drug Administered |
7.0% |
| Blood Pressure Decreased |
5.3% |
| Pneumothorax |
5.3% |
| Propofol Infusion Syndrome |
5.3% |
| Renal Failure Acute |
5.3% |
| Ventricular Fibrillation |
5.3% |
| Arteriospasm Coronary |
3.5% |
| Blood Chloride Decreased |
3.5% |
| Bradycardia |
3.5% |
| Cardiogenic Shock |
3.5% |
| Coma |
3.5% |
| Dermatitis Exfoliative |
3.5% |
| Drug Ineffective |
3.5% |
| Foetal Exposure During Pregnancy |
3.5% |
| Haemoglobin Decreased |
3.5% |
| Hepatitis Fulminant |
3.5% |
| Metabolic Acidosis |
3.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
46.5% |
| Drug Use For Unknown Indication |
31.9% |
| Coronary Artery Bypass |
5.0% |
| Prophylaxis |
1.9% |
| Catheterisation Cardiac |
1.6% |
| Aortic Valve Replacement |
1.5% |
| Multiple Myeloma |
1.3% |
| Hypertension |
1.1% |
| Pain |
1.1% |
| Cardiac Failure |
1.1% |
| Mitral Valve Replacement |
1.0% |
| Supportive Care |
0.8% |
| Sedation |
0.8% |
| Hypotension |
0.7% |
| Sepsis |
0.7% |
| Renal Transplant |
0.6% |
| Acute Coronary Syndrome |
0.6% |
| Infection Prophylaxis |
0.6% |
| Percutaneous Coronary Intervention |
0.6% |
| Premedication |
0.6% |
|
| Pain |
10.8% |
| Injury |
9.0% |
| Unevaluable Event |
8.8% |
| Renal Failure |
7.6% |
| Anxiety |
7.0% |
| Fear |
6.5% |
| Anhedonia |
4.8% |
| Sepsis |
4.5% |
| Death |
4.3% |
| Vomiting |
4.3% |
| Emotional Distress |
4.2% |
| Renal Impairment |
4.1% |
| Thrombocytopenia |
4.1% |
| Stress |
3.7% |
| Hypotension |
3.1% |
| Renal Failure Acute |
3.1% |
| Ventricular Tachycardia |
3.1% |
| Multi-organ Failure |
2.4% |
| Renal Injury |
2.3% |
| Shock |
2.3% |
|
| Interacting |
| Depression |
33.3% |
| Ill-defined Disorder |
33.3% |
| Psychomotor Retardation |
33.3% |
|
|
